NFL Chief Medical Officer Allen Sills thinks it’s “really important” for the league to research marijuana as a potential way to treat pain among its players.
Allen Sills — hired in March as the league’s first CMO — said in a Wednesday interview with The Washington Post the league still has a lot to learn about marijuana’s use as a pain medication.
“Certainly the research about marijuana … as (it) may relate to the treatment of both acute and chronic pain, that is an area of research that we need a lot more information on and we need to further develop,” Sills said.
His comments echo the NFL’s recent offer to work with the NFLPA on researching medical marijuana. As it stands, the league prohibits its use, even with 29 states legalizing it for medical use. This comes after a study recently found CTE in the brains of 110 of 111 former NFL players.
“We want to talk about health and safety issues that affect the whole player experience,” Sills said. “And certainly pain management is a big part of that.”